{
  "purpose": "Builds an economic case for WHY certain Indian states/sectors attract large domestic-conglomerate capital while others attract foreign FDI, using India's own two-tier cost-of-capital structure (RBI policy rate, bank MCLR/EBLR, AAA corporate bond yields) benchmarked against target FDI-source countries' central bank rates, and cross-checked against ICRA's sector-risk outlooks for whether credit-risk framing itself explains the pattern.",
  "retrieved": "2026-07-19",
  "method": "3 research passes: (1) RBI policy rate trajectory + bank MCLR/WALR/EBLR data + how large conglomerates (Tata, Reliance, Adani, JSW) actually finance capex, all primary-sourced (RBI/PIB, bank rate-notification pages, company NCD prospectuses); (2) central bank policy rates for 9 target FDI-source countries; (3) ICRA (India's Moody's-affiliated rating agency) sector-outlook notes for all 10 priority sectors, explicitly checking whether ICRA differentiates risk-absorption capacity between large and small players. State-level domestic-vs-FDI evidence reuses this repo's own prior sourced findings (fdi_vs_pli_launch_2026-07-19.json, state_central_incentives_and_emergent_hubs_2026-07-18.json) rather than re-deriving it.",

  "india_cost_of_capital": {
    "rbi_repo_rate": {"current": 5.25, "as_of": "2026-06-05 (61st MPC, held)", "corridor": "SDF 5.00% / repo 5.25% / MSF 5.50%", "stance": "neutral", "trajectory": "Cut 125bp cumulatively Feb-Dec 2025 (6.50%->5.25%), the most aggressive easing cycle since 2019, then held for 3 consecutive meetings (Feb, Apr, Jun 2026) into mid-2026 -- domestic policy-rate capital is at a multi-year low but no longer falling.", "source": "RBI MPC statements via PIB; next meeting 2026-08-03/05"},
    "bank_mclr_1yr": [
      {"bank": "SBI", "rate": 8.70, "effective": "2026-01-15", "note": "a further Jul 2026 revision was reported but the exact new figure could not be confirmed"},
      {"bank": "HDFC Bank", "rate": 8.45, "effective": "2026-07-07"},
      {"bank": "ICICI Bank", "rate": 8.35, "effective": "2026-01-22", "note": "stale by ~6 months; no confirmed Jul 2026 figure found"},
      {"bank": "PNB", "rate": 8.80, "effective": "2026-07-01"},
      {"bank": "Bank of Baroda", "rate": 8.75, "effective": "2026-06-12, reviewed unchanged 2026-07-12"}
    ],
    "system_wide_median_1yr_mclr": {"value": 8.50, "as_of": "2026-06", "source": "RBI data via press reporting"},
    "walr_fresh_rupee_loans": {"value": 8.51, "as_of": "2026-05", "note": "all-sector; no industry-specific WALR series was found -- flagged as a data gap, not estimated"},
    "walr_outstanding_loans": {"value": 8.98, "note": "legacy back-book, higher than fresh-loan rate due to slower MCLR transmission"},
    "eblr_shift": {
      "eblr_share_of_outstanding_floating_loans": {"end_2025_12": 65.5, "end_2026_03": 67.6},
      "mclr_share_of_outstanding_floating_loans": {"end_2025_12": 32.0, "end_2026_03": 30.2},
      "implication": "External-benchmark (repo-linked) pricing is now the dominant mechanism for over two-thirds of the banking system's floating-rate book, not just retail/MSME as originally mandated in 2019 -- large corporate term loans (the kind that funds a steel plant or gigafactory) are now typically EBLR-priced (repo + spread), not legacy MCLR. One illustrative EBLR: 10.35% (repo 5.25% + 5.10% spread, smaller bank; large blue-chip borrowers get tighter spreads)."
    },
    "aaa_corporate_bond_yields": {
      "1_3yr": "7.5-8.0%", "3_5yr": "7.4-8.3%", "5_10yr": "8.5-9.0%", "10yr_gsec_benchmark": 6.9,
      "note": "True AAA issuers (Tata Sons-backed entities, Reliance Industries) raise 3-5yr money at roughly 7.4-8.3% -- meaningfully BELOW the ~8.5% WALR and ~9.5-10.5% EBLR-priced loans facing ordinary corporate borrowers. Adani-rated paper (AA-, one notch below AAA) pays a real premium: its Jan 2026 public NCD issue priced at 8.48-8.90% coupon."
    },
    "two_tier_finding": "India's domestic cost of capital is NOT one number. AAA-rated national-champion conglomerates (Tata, Reliance) access ~7.4-8.3% via bonds/internal accruals; ordinary mid-market industrial borrowers face ~8.5% WALR to ~9.5-10.5% EBLR-priced bank loans -- a real, quantifiable 100-250+ basis point gap between the cheapest and most common tier of domestic capital."
  },

  "foreign_target_country_rates": [
    {"country": "Japan", "bank": "Bank of Japan", "rate": 1.00, "decision_date": "2026-06-16", "trajectory": "gradual hiking/normalization from near-zero, highest since Sep 1995"},
    {"country": "Taiwan", "bank": "Central Bank of the Republic of China", "rate": 2.00, "decision_date": "2026-Q2", "trajectory": "held for a 9th straight quarter"},
    {"country": "Eurozone (Germany, France)", "bank": "European Central Bank", "rate": 2.25, "decision_date": "2026-06-11", "trajectory": "first hike in 3 years after a long cutting cycle, Middle-East-conflict-linked inflation"},
    {"country": "Denmark", "bank": "Danmarks Nationalbank", "rate": 1.85, "decision_date": "2026-06-11", "trajectory": "hike reverses a long cutting cycle, mechanically tracks ECB to defend the krone peg"},
    {"country": "South Korea", "bank": "Bank of Korea", "rate": 2.75, "decision_date": "2026-07-16", "trajectory": "fresh hiking cycle (first since Jan 2023) after 8 straight holds, on inflation/won weakness"},
    {"country": "USA", "bank": "Federal Reserve", "rate": 3.625, "rate_range": "3.50-3.75%", "decision_date": "2026-06-17", "trajectory": "cut 175bp Sep-Dec 2025, held through H1 2026"},
    {"country": "UAE", "bank": "Central Bank of the UAE", "rate": 3.65, "decision_date": "2026-06-17 (reaffirmed)", "trajectory": "mechanically tracks the Fed via the AED/USD peg, held since Dec 2025"},
    {"country": "Israel", "bank": "Bank of Israel", "rate": 3.50, "decision_date": "2026-07-06", "trajectory": "active cutting cycle, ~100bp cumulative easing over 7 months on a strong shekel and war de-escalation"},
    {"country": "Saudi Arabia", "bank": "Saudi Central Bank (SAMA)", "rate": 4.25, "decision_date": "2025-12-10 (held since)", "trajectory": "mechanically tracks the Fed via the SAR/USD peg"}
  ],
  "rate_gap_finding": "Every one of the 9 target FDI-source countries' policy rates sits below India's 5.25% repo rate -- from 4.25 percentage points cheaper (Japan) to 1.6 points cheaper (Saudi Arabia). Against India's ORDINARY borrower rate (EBLR ~9.5-10.5%), the gap is far larger still (roughly 6-8.5 points). But against India's CHEAPEST tier (AAA bonds, 7.4-8.3%), the gap narrows considerably for the US, UAE, Israel and Saudi Arabia (1.5-3 points) -- meaning the 'foreign capital is cheaper' story is strongest when the domestic alternative is an ordinary mid-market borrower, and weakest when the domestic alternative is a AAA conglomerate. Caveat: these are CENTRAL BANK POLICY rates, not actual corporate borrowing costs in each country -- a real German or Japanese company's own funding cost runs above its central bank's policy rate by some spread, narrowing the true gap further. Two countries (Japan, Korea) are also mid-hiking-cycle as of this data, so the gap is closing in real time for those two specifically.",

  "icra_sector_risk_crosscheck": [
    {"sector": "Aircraft & Spacecraft / Defence", "outlook": "Positive (Jun 2025)", "differentiation_found": true, "strength": "strongest in this set", "finding": "ICRA explicitly states DPSUs (government-owned) get sizeable government mobilisation advances for working capital, while private entities -- regardless of size -- must raise equity via QIP/preferential allotment to fund the sector's 400+ day operating cycle. This is a state-vs-private axis, not strictly large-vs-small-private, but it shows non-state capital faces a structurally harder financing path that only well-capitalized private groups can repeatedly access."},
    {"sector": "Inorganic Chemicals / Plastics (Petrochemicals)", "outlook": "Negative (Apr 2026, West Asia conflict-driven)", "differentiation_found": true, "strength": "moderate, reframed as diversification not size", "finding": "ICRA states players with limited exposure to Middle East feedstock/export routes are less likely to see major swings -- a geographic-diversification differentiator that in practice tends to favor larger, more diversified players (e.g. Reliance-scale), though ICRA does not frame it as large-vs-small directly."},
    {"sector": "White Goods Components", "outlook": "no sector-wide label; RAC sub-segment note, Sep 2025", "differentiation_found": "partial", "strength": "structural fact, not a stated risk thesis", "finding": "ICRA states ~80% of RAC capacity is concentrated in the top 7 OEMs, with contract manufacturing limited to 3-4 companies -- the segment is already large-player-dominated as a structural fact, though ICRA doesn't explicitly frame this as a risk-absorption argument."},
    {"sector": "Pharmaceuticals & Bulk Drug APIs", "outlook": "Stable (Sep 2025)", "differentiation_found": "weak/implicit", "strength": "weak", "finding": "ICRA's own analytical sample is limited to the 25 leading pharma companies (~60% of industry revenue) -- the Stable outlook is inherently a large-player view. ICRA notes debt-funded acquisitions signal 'rising risk appetite among leading players' specifically, implying only leading firms have the balance-sheet capacity for inorganic growth, but does not directly contrast this against smaller generic players."},
    {"sector": "Auto, EV & Battery", "outlook": "8-10% revenue growth FY26, moderating (Feb 2025, revised down Dec 2025 on US tariffs)", "differentiation_found": "weak/indirect", "strength": "weak", "finding": "A press snippet references 'comfortable liquidity, especially across tier-I players' -- implying larger/more diversified suppliers are better positioned than lower-tier vendors, but ICRA does not spell out an explicit scale-based risk thesis the way it does for Defence."},
    {"sector": "Specialty Steel & Metals", "outlook": "Stable (Dec 2025)", "differentiation_found": false, "strength": "explicitly absent -- important honesty finding", "finding": "ICRA's Dec 2025 steel note discusses industry-wide leverage (TD/OPBDITA rising to 3.4x) and margin risk from Chinese oversupply WITHOUT segmenting by company scale. An earlier automated summary pass had fabricated a claim that ICRA differentiates Tata Steel/JSW/Jindal's risk-absorption capacity from smaller players in this release -- that claim was checked against the actual source PDF and found unsupported, then explicitly retracted. This is flagged here precisely because Steel is the sector most associated with the large-conglomerate names this analysis discusses, making the absence of ICRA differentiation the single most important caveat against over-claiming the cost-of-capital story."},
    {"sector": "Textiles & Apparel", "outlook": "Upgraded Negative->Stable (Feb 2026, on US tariff rollback)", "differentiation_found": false, "strength": "not found", "finding": "No ICRA language distinguishing large integrated exporters from smaller job-work units was found in accessible 2025-2026 notes -- flagged as an incomplete sub-finding, not asserted."},
    {"sector": "Electronics & Semiconductor Manufacturing", "outlook": "no sector-wide ICRA note found", "differentiation_found": null, "strength": "not applicable -- genuine coverage gap", "finding": "ICRA covers this space only at individual-company (mostly EMS/PCB manufacturer) level -- e.g. IL JIN Electronics and HI-Q Electronics rating rationales cite execution risk and import-led working-capital intensity, but no synthesized sector-wide outlook with a Stable/Negative label exists. Not substituting another rating agency's view to fill this gap."},
    {"sector": "Medical Devices", "outlook": "no sector-wide ICRA note found", "differentiation_found": null, "strength": "not applicable -- genuine coverage gap", "finding": "Same as Electronics -- only company-level rationales exist (NPPA pricing-cap risk, 55-70% import-dependent raw materials for individual rated names like Meril, Trivitron), no sector-wide ICRA thesis."}
  ],

  "state_financing_pattern": [
    {"state": "Assam", "flagship_project": "Tata Electronics ATMP, Jagiroad", "amount": "Rs 27,000cr", "financing_type": "domestic", "financer": "Tata Sons (AAA-rated)", "case_type": "domestic", "reasoning": "A pure-play Tata Sons subsidiary, funded on Tata's AAA balance-sheet access to ~7.4-8.3% bonds -- cheaper than what a foreign JV partner's blended India-risk-adjusted cost of capital would likely be for a facility with no existing foreign technology dependency (ATMP/packaging, not core fab process). Assam's actual FDI equity inflow (FY2024-25: $2.88M) confirms no foreign capital is involved."},
    {"state": "Odisha", "flagship_project": "Tata Steel Kalinganagar + Jindal Stainless Jajpur", "amount": "~Rs 50,000cr + Rs 2-3,000cr", "financing_type": "domestic", "financer": "Tata Steel, Jindal Stainless", "case_type": "domestic", "reasoning": "Steel is the sector ICRA explicitly does NOT differentiate by scale (see icra_sector_risk_crosscheck) -- yet Tata/Jindal self-fund anyway. This suggests the domestic-capital choice here is driven less by a documented risk-absorption advantage and more by strategic self-reliance motives (steel security) plus straightforward access to the cheapest domestic bond tier, independent of ICRA's risk framing."},
    {"state": "Gujarat (battery/auto)", "flagship_project": "Tata Agratas + Reliance Jamnagar battery gigafactories", "amount": "~Rs 13,000cr (Agratas phase 1) + Jamnagar (undisclosed)", "financing_type": "domestic", "financer": "Tata Motors/Sons, Reliance Industries", "case_type": "domestic", "reasoning": "Both India's two largest, cheapest-capital-access conglomerates, building strategic EV/battery capacity with no existing foreign-owned domestic incumbent to license from at scale -- a textbook case for AAA-tier self-funding over foreign JV dilution."},
    {"state": "Gujarat (semiconductors)", "flagship_project": "Micron Sanand ATMP; Tata-PSMC Dholera fab", "amount": "$2.75bn (Micron); Rs 91,000cr (Tata-PSMC JV)", "financing_type": "mixed", "financer": "Micron (US, foreign) for Sanand; Tata (domestic) + PSMC (Taiwan, foreign tech partner) JV for Dholera", "case_type": "mixed", "reasoning": "Gujarat is the one state that clearly hosts BOTH cases side by side: Micron's own capital is genuine US FDI (process technology only Micron holds), while Dholera is majority-domestic capital paired with Taiwanese PROCESS KNOW-HOW rather than Taiwanese equity -- consistent with the country-strategy finding that Taiwan is a technology partner, not primarily a capital source."},
    {"state": "Andhra Pradesh", "flagship_project": "Daikin-Rechi compressor JV, LG Electronics Sri City plant", "amount": "Rs 547cr (Daikin ph.1) + Rs 5,001cr (LG)", "financing_type": "foreign", "financer": "Daikin (Japan), LG (Korea)", "case_type": "fdi", "reasoning": "Neither Daikin's compressor engineering nor LG's appliance R&D has a scaled domestic-conglomerate equivalent in India -- the technology itself is foreign-owned, so equity FDI is not a financing choice but closer to a requirement. Both companies' home policy rates (Japan 1.00%, Korea 2.75%) are 2.5-4.25 points below India's repo rate, reinforcing rather than solely explaining the FDI route."},
    {"state": "Tamil Nadu", "flagship_project": "Samsung Sriperumbudur compressor plant; Ola Electric Krishnagiri", "amount": "Rs 1,588cr (Samsung) vs. Rs 7,614cr (Ola)", "financing_type": "mixed", "financer": "Samsung (Korea, foreign) vs. Ola Electric (Indian, domestic)", "case_type": "mixed", "reasoning": "A single state hosting the clearest side-by-side contrast in this dataset: Samsung brings foreign compressor technology and Korean capital; Ola Electric (an Indian company, despite earlier foreign VC/PE funding rounds) self-funds its battery/EV capacity domestically -- same state, same broad sector cluster (electrical/auto components), opposite financing sources, because the underlying technology ownership differs."},
    {"state": "Maharashtra", "flagship_project": "Nidec/Embraco compressor plant (Chhatrapati Sambhajinagar); VW/Mercedes/Stellantis auto plants", "amount": ">$120M (Nidec) + multiple foreign OEM plants", "financing_type": "foreign", "financer": "Nidec (Japan), Volkswagen/Mercedes-Benz/Stellantis (Germany/EU/multinational)", "case_type": "fdi", "reasoning": "Maharashtra's Pune-Chakan-Talegaon auto belt is disproportionately foreign-OEM-dominated (VW, Mercedes, Stellantis) compared to Tamil Nadu's or Gujarat's more domestic-conglomerate-heavy clusters -- these are foreign brands building India capacity to serve the Indian market directly, not technology-transfer JVs, and Germany/Eurozone's 2.25% policy rate sits 3 points below India's."},
    {"state": "Karnataka", "flagship_project": "JSW Vijayanagar steel expansion; Ola Electric HQ/Battery Innovation Centre", "amount": "Rs 15,000cr (JSW) + $500M (Ola)", "financing_type": "domestic", "financer": "JSW, Ola Electric", "case_type": "domestic", "reasoning": "Karnataka's manufacturing-hub investment (Bellary-Hospet steel, Bengaluru battery/EV) is domestic-conglomerate-funded, even though the state's HEADLINE FDI statistics are dominated by an unrelated effect (Bengaluru's software/IT-services economy, per the state_level_findings HQ-attribution issue) -- a reminder that a state's aggregate FDI number and its actual manufacturing-hub financing pattern can point in different directions entirely."},
    {"state": "Telangana", "flagship_project": "Genome Valley pharma cluster; Amara Raja battery gigafactory", "amount": "$1.49bn (Genome Valley, 2020-2024) + Rs 9,500cr (Amara Raja)", "financing_type": "mixed", "financer": "Genome Valley tenants include both foreign majors (Novartis, GSK, Roche, Sanofi, J&J, BMS) and Indian majors (Bharat Biotech, Biological E); Amara Raja is domestic", "case_type": "mixed", "reasoning": "Pharma is the sector where ICRA's Stable-outlook sample (the 25 leading firms) blends both foreign-owned and Indian-owned majors without a clean scale-based split -- consistent with Telangana's own mixed financing pattern, where global pharma majors co-locate with Indian biotech/battery conglomerates in the same cluster."}
  ],

  "the_case": {
    "for_domestic_capital": "Where a strategic, nationally-important capacity gap (steel security, semiconductor packaging, EV battery cells) coincides with an existing AAA/AA-rated Indian conglomerate (Tata, Reliance, JSW, Jindal, Adani) that ALREADY has the industrial scale and can access India's cheapest domestic capital tier (~7.4-8.3% via bonds and internal accruals, well below the ~9.5-10.5% an ordinary mid-market borrower or a foreign entrant's India-risk-adjusted cost of capital would likely face) -- domestic self-funding is not a policy failure to be corrected with more FDI courtship. It is close to the economically rational choice: it avoids equity dilution, preserves strategic control over capacity the government has explicit self-reliance motives to keep domestically controlled, and the capital is not meaningfully more expensive than the FDI alternative once realistic spreads are applied. This describes Assam (Tata Electronics), Odisha (Tata Steel/Jindal), Gujarat's battery gigafactories (Tata Agratas/Reliance), and Karnataka's steel/EV clusters (JSW/Ola).",
    "for_foreign_fdi": "Where the enabling technology, brand, or engineering IP is foreign-owned and no scaled domestic incumbent holds an equivalent capability (Daikin's compressor engineering, Samsung/LG's appliance R&D, Siemens/Medtronic's medical-device technology, German OEMs' automotive platforms), foreign equity FDI is closer to a requirement than a financing choice -- an Indian company cannot simply borrow its way to owning technology it doesn't have. That this FDI also happens to be sourced against home-market policy rates 1.6 to 4.25 percentage points below India's repo rate (and further below India's EBLR-priced ordinary-borrower tier) reinforces the economics without being the primary driver. This describes Andhra Pradesh (Daikin, LG), Maharashtra's foreign-OEM auto belt (VW, Mercedes, Stellantis), and the foreign share of Tamil Nadu's white-goods-component cluster (Samsung).",
    "the_honest_caveat": "This is a plausible, partially-evidenced economic explanation, not a proven causal model. ICRA's own sector-risk framing -- which would be the clearest test of whether 'large players can absorb risk domestic capital markets price in' actually drives the domestic-financing choice -- is inconsistent: strong and explicit for Defence (DPSU-vs-private financing asymmetry), present but reframed as geographic diversification for Chemicals, a bare structural fact (not a risk argument) for White Goods, weak/implicit for Pharma and Auto, and EXPLICITLY ABSENT for Steel -- the sector most associated with the large-conglomerate names this case discusses. Two sectors (Electronics, Medical Devices) have no ICRA sector-wide view at all. The interest-rate gap is real and quantifiable, but it should be read as a permissive condition that makes domestic self-funding cheap enough to be viable, not as the sole or primary reason conglomerates choose it over FDI -- national self-reliance policy, technology availability, and control preferences are doing real work alongside the rate differential, and this dataset cannot cleanly separate their relative weights."
  }
}